Literature DB >> 26287988

Like-Charge Guanidinium Pairing between Ligand and Receptor: An Unusual Interaction for Drug Discovery and Design?

Yang Yang1, Zhijian Xu1,2, Zhengyan Zhang1,3, Zhuo Yang1, Yingtao Liu1, Jinan Wang1, Tingting Cai1, Shujin Li3, Kaixian Chen1, Jiye Shi4, Weiliang Zhu1.   

Abstract

A database survey in this study revealed for the first time that there are 227 counterintuitive like-charge guanidinium pairings (Gdm(+)-Arg pairings) between ligands and receptors in the Protein Data Bank, implying the potential guanidinium-arginine binding between guanidine-containing drugs and their target proteins. Furthermore, there are 145 guanidine-containing molecules in the DrugBank, showing the prevalence of guanidinium groups in drugs. It has also been reported that the introduction of a guanidinium group forming Gdm(+)-Arg pairing improved the potency of the drug by more than 8-fold in a typical case. On the basis of the survey, six ligand-protein complexes with typical Gdm(+)-Arg pairings were chosen for QM/MM calculations. The calculations at the B97-D/6-311++g(d,p) level revealed that the interaction could be as strong as -1.0 to -2.5 kcal/mol in DMSO and water, comparable to common intermolecular interactions. The calculations also unveiled that the Gdm(+)-Arg pairing interactions change from repulsive to attractive with the increase of dielectric constant, suggesting that the dielectric constant has a general stabilization effect on the Gdm(+)-Arg pairing. This study suggested that the like-charge guanidinium pairing interaction could be used not only for tuning the physical and chemical properties of drug leads but also for improving ligand binding affinity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26287988     DOI: 10.1021/acs.jpcb.5b04130

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  1 in total

1.  Structure-Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo Activity.

Authors:  Valentina Albanese; Chiara Ruzza; Erika Marzola; Tatiana Bernardi; Martina Fabbri; Anna Fantinati; Claudio Trapella; Rainer K Reinscheid; Federica Ferrari; Chiara Sturaro; Girolamo Calò; Giorgio Amendola; Sandro Cosconati; Salvatore Pacifico; Remo Guerrini; Delia Preti
Journal:  J Med Chem       Date:  2021-03-18       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.